CIK 0001439725 · Non-accelerated filer<br>Smaller reporting company
BIODESIX INC
Sign in to watch- Ticker
- BDSX
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203986492
- Phone
- 303-417-0500
- Business address
- 919 WEST DILLON ROAD, LOUISVILLE, CO, 80027
- 4 Open-market buy Director bought 26,641 shares at an average $1.36 ($36,156)
- 4 Open-market buy Director bought 52,508 shares at $1.36 ($71,280)
- 4 Open-market buy Director bought 35,308 shares at $1.25 ($43,980)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 4 Open-market buy Director bought 56,782 shares at $1.15 ($65,066)
- 4 Open-market buy Director bought 29,425 shares at $1.11 ($32,529)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Open-market sale CFO, Sec'y & Treasurer sold 3,485 shares at an average $1.57 ($5,468)
- 4 Open-market sale Chief Commercial Officer sold 1,697 shares at an average $1.57 ($2,663)
- 4 Open-market sale Chief Accounting Officer sold 2,020 shares at an average $1.57 ($3,170)
- 4 Open-market sale President & CEO sold 13,782 shares at an average $1.57 ($21,625)
Page 16 of 31 · 602 filings